Introduction: Hyperkalemia is a commonly encountered clinical problem. Pseudohyperkalemia is believed to be an in vitro phenomenon that does not reflect in vivo serum potassium and therefore should not be treated. Here, we present a case who unfortunately underwent unnecessary treatment because of failure to detect the common lab abnormality of pseudohyperkalemia.
Case Presentation: A 91-year-old female with a history of chronic lymphocytic leukemia presented to the emergency with nausea and vomiting 24 hours after her first chemotherapy with chlorambucil. Physical examination was overall unremarkable. She had a leukocytosis of 210 × 10/L with 96% lymphocytes along with chronic anemia with hemoglobin of 8.1 g/dL. Her initial sodium and potassium levels were normal. During the clinical course, her potassium progressively worsened and failed to improve despite standard medical treatment. Patient ultimately underwent dialysis.
Conclusions: Differentiating true hyperkalemia from pseudohyperkalemia is very important in selected group of patients to avoid unnecessary medications, higher level of care, and unnecessary procedure including dialysis. We want to emphasize the importance of simple yet profound knowledge of technique of blood draws and basic metabolic panel processing for every clinician in day-to-day practice.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081547 | PMC |
| http://dx.doi.org/10.1155/2018/9060892 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Time as a significant factor in the release of potassium from lithium heparin plasma and serum.
PLoS One
December 2024
LADR Laboratory Group Dr. Kramer & Kollegen, Geesthacht, Germany.
Objectives: In most countries the majority of patients are in outpatient care. In difference to hospitalized patients, their blood samples often take hours after collection to centrifugation. The study investigates the release of potassium and the development of pseudohyperkalemia in lithium heparin (Li-Hep) and serum blood collection tubes over time.
View Article and Find Full Text PDFThe Paradox of Hyperkalaemia: When Treatment Isn't the Answer.
Cureus
September 2024
Acute and General Internal Medicine, University Hospitals Bristol and Weston, Weston-super-Mare, GBR.
Article Synopsis
- Hyperkalaemia is a serious medical emergency that requires immediate treatment, but there is uncertainty about the exact level at which treatment should start due to different clinical situations.
- The case report focuses on an 89-year-old man with frequent falls and unstable potassium levels, who did not exhibit symptoms of hyperkalaemia and lacked a significant drug history.
- Further examination identified a myeloproliferative neoplasm causing thrombocytosis, leading to a diagnosis of pseudohyperkalaemia, which emphasizes the importance of distinguishing between true hyperkalaemia and pseudohyperkalaemia in patients with blood disorders.
Pneumatic tube transport-induced pseudohyperkalemia in patients with extreme leukocytosis: a retrospective study from a single medical center.
Int J Hematol
November 2024
Department of Surgery, China Medical University Hospital, No. 2, Yude Rd., North Dist., Taichung City, 404327, Taiwan.
Article Synopsis
- Pseudohyperkalemia, a condition characterized by falsely high potassium levels, can be confused with true hyperkalemia, leading to unnecessary treatments; it is important to differentiate between the two.
- A study analyzed 1188 blood samples and found that pneumatic tube transportation was associated with a higher occurrence of pseudohyperkalemia, particularly when white blood cell (WBC) counts were elevated (≥ 100 × 10/μL).
- The results indicate that for every increase of 100 × 10/μL in WBC count, the likelihood of pseudohyperkalemia increased significantly (multiplied by 3.75), suggesting that careful sample handling is crucial for accurate potassium level assessment
Hyperkalemia presentation at a clinic during the cold season.
CEN Case Rep
June 2024
Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-Ku, Kawasaki, Kanagawa, 216-8511, Japan.
Familial pseudohyperkalemia (FP) is an underrecognized cause of pseudohyperkalemia, caused by the leaking of potassium from red blood cells. This extracellular shift of potassium is temperature-dependent and occurs when blood samples are stored below room temperature or for a long time, manifesting as apparent hyperkalemia. We report a suspicious case of FP, which demonstrated an apparent seasonal trajectory of serum-potassium levels at the local clinic.
View Article and Find Full Text PDFPseudohyperkalemia in pediatric patients with newly diagnosed hematological malignancies.
Pediatr Hematol Oncol
October 2024
Division of Nephrology, Department of Pediatrics, Taichung Veterans General Hospital, Taichung, Taiwan.
Patients with newly diagnosed hematological malignancies often present with a considerable cellular burden, leading to complications including hyperkalemia. However, pseudohyperkalemia, arising from cell lysis, can pose challenges in clinical practice. Although pseudohyperkalemia is frequently reported in adult hematological malignancies, its occurrence in pediatric patients is underreported, and its incidence in this demographic remains unclear.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!